Grace S. Liang, MD
- 2Articles
- 19.9KReads1
- 2017–2018Active
- 10Collaborators
- 81Citations2
About
Grace S. Liang, MD, has published research focused on the treatment of tardive dyskinesia, specifically examining the effects of valbenazine. Liang's work includes analysis of clinical trial data from the KINECT 3 study and its one-year extension, contributing to the understanding of treatment outcomes in this neurological condition. Collaborations include frequent co-authors Christoph U. Correll, Christopher F. O'Brien, Andrew J. Cutler, Cynthia L. Comella, and Gary Remington.
Publications
Valbenazine for Tardive Dyskinesia: Results From the KINECT 3 Study
December 18, 2018
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
